Jiangsu Nhwa Pharmaceutical Co., Ltd.
002262
株式のランク
#4605
Jiangsu Nhwa Pharmaceutical Co., LTD operates as a global pharmaceutical... Jiangsu Nhwa Pharmaceutical Co., LTD operates as a global pharmaceutical entity, focusing on the research, production, and sale of treatments for the central nervous system, along with cardiovascular and cerebrovascular ailments. Its comprehensive product line includes therapeutics for anesthesia, psychiatry, and neurological disorders. Additionally, the company is a supplier of Active Pharmaceutical Ingredients (APIs), specifically for central nervous system, anesthetic, and sedative applications, among others. The firm was established in 1978 and is based in Xuzhou, China.
株価
$3.28
時価総額
$3.32B
変化（1日）
4.19%
変化（1年）
-10.41%
国
CN
取引 Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262)
カテゴリー
Healthcare
Jiangsu Nhwa Pharmaceutical Co., Ltd.（002262）の利益
Jun 2026 時点の利益 TTM: $178.32M
Jiangsu Nhwa Pharmaceutical Co., Ltd. の最新の財務報告によると、同社の現在の利益は $178.32M です。2023 年には $165.10M の利益を上げ、これは 2022 年の利益 $143.51M と 増加 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Jiangsu Nhwa Pharmaceutical Co., Ltd. の利益の推移（2005 〜 2026）
各年末の利益
| 年 | 利益 | 変化 |
|---|---|---|
| 2026 (TTM) | $178.32M | 0.37% |
| 2024 | $177.65M | 7.60% |
| 2023 | $165.10M | 15.04% |
| 2022 | $143.51M | -0.40% |
| 2021 | $144.08M | 10.67% |
| 2020 | $130.19M | 18.18% |
| 2019 | $110.16M | 24.59% |
| 2018 | $88.42M | 29.21% |
| 2017 | $68.43M | 32.53% |
| 2016 | $51.63M | 11.41% |
| 2015 | $46.35M | 10.03% |
| 2014 | $42.12M | 24.43% |
| 2013 | $33.85M | 27.40% |
| 2012 | $26.57M | 38.55% |
| 2011 | $19.18M | 40.39% |
| 2010 | $13.66M | 48.52% |
| 2009 | $9.20M | 26.55% |
| 2008 | $7.27M | 35.65% |
| 2007 | $5.36M | 134.21% |
| 2006 | $2.29M | 10.87% |
| 2005 | $2.06M | 0.00% |
同業他社の利益
| 企業 | 利益 | 利益の差 | 国 |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | 889.56% |
IN
|
